Stakeholder News
The CREID Network collaborates with a wide variety of external stakeholders including from the US Government, foreign governments, multilateral institutions such as the World Health Organization, foundations and nonprofits, such as CEPI, Wellcome Foundation, and the private sector. If you are interested in exploring a collaboration with the CREID Network, please contact info@creid-network.org.
|
|
|
WHO's Science in 5 - Disease X
WHO is a CREID Network stakeholder and a WHO representative sits on the CREID Network External Advisory Committee.
How are scientists working to prevent the next pandemic? What do countries need to do to prepare? Ana Maria Henao-Restrepo outlines the R&D needs that the world needs to invest in to prevent and prepare for the next pandemic.
|
|
|
Research Center Updates
The April 2024 quarterly newsletter features 2 of the CREID Research Centers: CREATE-NEO and UWARN. In addition to working in the US, these 2 Research Centers work in Brazil and Panama (CREATE-NEO); and Brazil, Pakistan, Senegal, South Africa, Switzerland, and Taiwan.
Please see more information about each of the 10 Research Centers at the CREID Network website.
|
|
|
CREATE-NEO/FAMERP Postdoctoral Fellow Dr. Lívia Sacchetto trains colleagues from Paraguay’s Universidad Nacional de Asunción on next-generation sequencing (NGS) for real-time genomic surveillance and outbreak research. |
|
CREATE-NEO
CREATE-NEO investigators at the Faculdade de Medicina de São José do Rio Preto (FAMERP) alerted Brazilian health authorities to impending explosive twin outbreaks, after identifying cryptic chikungunya virus circulation in humans and vectors and the emergence of Dengue virus serotype-3 to naïve populations. Concurrently, the program expanded regional capacity for real-time genomic surveillance and outbreak research through South-to-South training and support.
Award Number U01AI151807
 |
|
|
UWARN
UWARN partners, Dr. Abdou Padane and colleagues at the Institute for Health Research, Epidemiological Surveillance and Training (IRESSEF), Senegal, discovered, in real-time, an emerging clade of the Chikungunya West African genotype, phylogenetically distinct from previous outbreaks, during the 2023 CHIKV outbreak in Senegal. The Abbott Pandemic Defense Coalition (APDC) and the Center for Epidemic Response and Innovation (CERI) in South Africa, supported Dr. Padane with a fellowship to establish West African Dengue surveillance, offering protocols, reagents, consumables, ongoing data analysis assistance, and enriching his skills, which included gaining expertise in whole genome sequencing (WGS) and epidemic response. Dr. Padane utilized these skills to detect, sequence, and identify this novel CHIKV strain.
Award Number U01AI151698
|
|
IRESSEF Implementing Whole Genome Sequencing (WGS) for genomic surveillance.
Legend, from lower left, moving counter-clockwise: Dr. Abdou Padane, who trained at CERI/APDC/UWARN, South Africa, is seen inputting parameters into an IRESSEF TapStation machine to quantify DNA fragment size before sequencing; Dr. Padane is shown training an IRESSEF team (Dr. Cyrille Diedhiou, Dr. Marièma Sarr, Mrs. Ndèye Astou Dabo, Mrs. Ndèye Dieynaba Diouf) in WGS wet-lab, the IRESSEF team (Dr. Abdou Padane, Dr. Cyrille Diedhiou, Dr. Marièma Sarr, Mrs. Ndèye Astou Dabo, Mrs. Ndèye Dieynaba Diouf) executes wet-lab WGS.
|
|
|
|
|
